Eicosanoids. Critical agents in the physiological process and cellular injury

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• Eicosanoids, initially identified as prostaglandins, are ubiquitous in mammalian cells.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) function by inhibiting eicosanoid synthesis enzymes.
• Arachidonic acid, a precursor fatty acid, is converted by cyclooxygenase and lipoxygenase enzymes into various eicosanoids.

Purpose of the Study:

• To explore the multifaceted roles of eicosanoids in biological systems.
• To highlight the involvement of eicosanoids in both normal physiological functions and disease states.
• To underscore the expanding understanding of eicosanoids as critical signaling molecules.

Main Methods:

• Literature review and synthesis of existing research on eicosanoid biochemistry and function.
• Analysis of the involvement of eicosanoids in cardiovascular, gastrointestinal, and inflammatory processes.
• Examination of the interplay between eicosanoids and other signaling molecules like platelet-activating factor and tumor necrosis factor.

Main Results:

• Eicosanoids are integral to cardiovascular function, vascular disease, and ischemia.
• In the gastrointestinal tract, eicosanoids regulate functions like acid secretion and motility, and are implicated in inflammatory bowel and peptic ulcer diseases.
• Eicosanoids play significant roles in sepsis and endotoxemia, and mediate effects of platelet-activating and tumor necrosis factors.

Conclusions:

• Eicosanoids are key phospholipid mediators with diverse physiological and pathological roles.
• Their involvement spans multiple organ systems and disease conditions, including cardiovascular and gastrointestinal disorders.
• Future research is expected to further elucidate their critical roles in intracellular events and systemic effects.